Results 181 to 190 of about 731,751 (310)

Post-marketing safety of solriamfetol: A retrospective pharmacovigilance study based on the us food and drug administration adverse event reporting system. [PDF]

PLoS One
Wu L, Zhu K.
europepmc   +1 more source

Thoracic Endovascular Aortic Repair Adverse Events Reported In The Food And Drug Administration Manufacturer And User Facility Device Experience Database

, 2019
Mansukhani NA, Haleem MS, Eskandari Mk
openalex   +1 more source

U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy [PDF]

, 2015
Erin Larkins, Barbara Scepura, Gideon M. Blumenthal, Erik Bloomquist, Shenghui Tang, Missiratch Biable, Paul G. Kluetz, Patricia Keegan, Richard Pazdur   +8 more
openalex   +1 more source

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

Journal of the American Medical Association (JAMA), 2017
Nicholas Downing, N. Shah, J. Aminawung, Alison M. Pease, J. Zeitoun, H. Krumholz, J. Ross   +6 more
semanticscholar   +1 more source

Next‐Generation Bio‐Reducible Lipids Enable Enhanced Vaccine Efficacy in Malaria and Primate Models

Advanced Functional Materials, EarlyView.
Structure–activity relationship (SAR) optimization of bio‐reducible ionizable lipids enables the development of highly effective lipid nanoparticle (LNP) mRNA vaccines. Lead LNPs show superior tolerability and antibody responses in rodents and primates, outperforming approved COVID‐19 vaccine lipids.
Ruben De Coen, Sabah Kasmi, Shrinivas Dumbre, Lies Baekens, Elise Seynaeve, Louise Van den Hauwe, Niccolò Cantini, Aello Garantoudi, Filipe Branco Madeira, Alain Marrot, Emma Tuypens, Sofie Seghers, Anna Kuchmiy, Elisabeth Brabants, Bart Vanderborght, Ine Maes, Sarah Vandenberghe, Jessica Filtjens, Alícia Gordún Peiró, Daliya Kancheva, Ayla Debraekeleer, Florence Lambolez, Emily De Lombaerde, Yong Chen, Rafael Miyazawa Martins, Pauline Formaglio, Damya Laoui, Sofie Deschoemaeker, Bruno G. De Geest, Rogerio Amino, Stefaan De Koker   +30 more
wiley   +1 more source

Response to Letter to the Editor Regarding <i>A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized Coronavirus Disease 2019 Treatments</i>. [PDF]

Open Forum Infect Dis
Maglione MA, Klausner J, Hempel S.
europepmc   +1 more source

From Failure to Meet the Clinical Endpoint to U.S. Food and Drug Administration Approval: 15th Antisense Oligonucleotide Therapy Approved Qalsody (Tofersen) for Treatment of SOD1 Mutated Amyotrophic Lateral Sclerosis

, 2023
Willeke M. C. van Roon‐Mom, Chantal Ferguson, Annemieke Aartsma‐Rus   +2 more
openalex   +2 more sources

Alginate‐Sludge Derived Biochar‐Calcium Hydrogel for Phosphate Removal and Slow‐Release Fertilizer: A Sustainable and Multifunctional Solution

Advanced Functional Materials, EarlyView.
An alginate‐based biochar hydrogel (ABC‐hydrogel), derived from sewage sludge, is developed for simultaneous phosphate removal and agricultural reuse. It captures phosphorus from water and gradually releases it as fertilizer, enhancing lettuce growth.
Yu Zhang, Baile Wu, Haoran Dong, Xiaohong Guan, Irene M. C. Lo   +4 more
wiley   +1 more source

Hardly a Windfall: Prescribing Practices in Pediatric Heart Failure Around Food and Drug Administration Approval. [PDF]

JACC Adv
Ludomirsky AB, Edelson JB, Lin KY, Berger JH, O'Connor MJ, Wittlieb-Weber CA, Griffis H, Zhang B, Rossano JW.   +8 more
europepmc   +1 more source

The U.S. Food and Drug Administration announcement suggests the need to revisit guidelines for antibiotic use after EUS-FNA [PDF]

, 2016
Navin Paul
openalex   +1 more source